{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Menopausal Hormone Therapy and the Mind: The Role of Hormone Replacement in the Prevention and Treatment of Cognitive Decline, Dementia, and Cognitive Dysfunction of Depression

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Outline the clinical recommendations for menopausal hormone treatment related to cognitive concerns
  2. Debate and discuss the various research pieces on the use of menopausal hormone therapy for cognitive decline, dysfunction, and dementia.

Disclosures

The authors, faculty, staff, and planners of this CME/NCPD activity have no relevant financial relationships with any ineligible organizations relevant to this educational activity.

Disclaimer

Clinicians should ensure that all diagnostic and therapeutic modalities are prescribed and used appropriately, based on accepted standards of care. Use of any drugs, devices, and imaging techniques should be guided by approved labeling/full prescribing information, best available evidence, and professional judgment. Faculty have been instructed that their content should be fair balanced and based on best available evidence. The information presented in this activity is the responsibility of the faculty and does not reflect the opinions of the provider.

Price: $12.95

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner
Professions: Physician
Test Code: HRP0722
Published: July/August 2022
Expires: 7/31/2024
Sources: Harvard Review of Psychiatry
Required Passing Score: 7/10 (70%)
Authors: Amanda Koire, MD, PhD, Hadine Joffe, MD, MSc, and Rachel Buckley, PhD
Categories: Psychiatric
Specialties: Psychiatry
Topics: Hormone Therapy , Menopause